Lydia Kalafateli

Venture Developer & Biotech Domain Lead

Lydia joined NLC in April 2022 as a Venture Developer in the Biotech domain. She holds a BSc in Biology from Greece, an MSc in Pharmacology from the Netherlands, a PhD in Neuroscience from Sweden and an MBA. After 9+ years of R&D experience in academic and industrial settings (including Yale University and AstraZeneca), she developed a strong interest in the business/commercial side of Life Sciences. Currently, she leads the Biotech domain at NLC and builds successful Biotech companies bringing innovative therapeutics to patients in need.

NLC Health Ventures Footer